Normativa otros países
Feb. 22, 2012Canadá: autorización provisional de comercialización de nueva encima xilanasa en la producción de pan, harina, harina integral de trigo y productos de panificación (galletas y pasteles)
World Trade
Organization |
|
G/SPS/N/CAN/585
26 January 2012 |
|
(12‑0510) | |
Committee on Sanitary and Phytosanitary Measures | Original: English/ French |
NOTIFICATION
1. | Notifying Member: CANADA
If applicable, name of local government involved: |
2. | Agency responsible: Health Canada |
3. | Products covered (provide tariff item number(s) as specified in national schedules deposited with the WTO; ICS numbers should be provided in addition, where applicable): Bread, flour, whole wheat flour and unstandardized bakery products such as cookies and cakes (ICS Codes: 67.060, 67.220) |
4. | Regions or countries likely to be affected, to the extent relevant or practicable:
[X] All trading partners [ ] Specific regions or countries: |
5. | Title of the notified document: Interim Marketing Authorization regarding the use of xylanase derived from Bacillus subtilis strain XAS in the production of bread, flour, whole wheat flour and unstandardized bakery products such as cookies and cakes Language(s): English and French Number of pages: 2 |
6. | Description of content: Health Canada has received a submission to permit the use of xylanase derived from Bacillus subtilis strain XAS in the production of bread, flour, whole wheat flour and unstandardized bakery products such as cookies and cakes at levels consistent with good manufacturing practice. Evaluation of available data supports the safety and effectiveness of xylanase derived from Bacillus subtilis (XAS) in these food products.
Therefore, it is the intention of Health Canada to recommend that the Regulations be amended to permit the use of xylanase derived from Bacillus subtilis (XAS) in the production of bread, flour, whole wheat flour and unstandardized bakery products at levels consistent with good manufacturing practice. As a means to improve the responsiveness of the regulatory system, an Interim Marketing Authorization (IMA) is being issued to permit the immediate use of this xylanase enzyme, as indicated above, while the regulatory process is undertaken to amend the Regulations. The proposed regulatory amendments would be enabling measures to allow the sale of the additional foods mentioned above that have been manufactured through the use of xylanase derived from Bacillus subtilis (XAS). The amendments are supported by the safety assessment and would have low impact on the economy and on the environment. Consequently, the regulatory amendments may proceed directly to final approval and publication in the Canada Gazette, Part II. |
7. | Objective and rationale: [X] food safety, [ ] animal health, [ ] plant protection, [ ] protect humans from animal/plant pest or disease, [ ] protect territory from other damage from pests. |
8. | Is there a relevant international standard? If so, identify the standard:
[ ] Codex Alimentarius Commission (e.g. title or serial number of Codex standard or related text) [ ] World Organization for Animal Health (OIE) (e.g. Terrestrial or Aquatic Animal Health Code, chapter number) [ ] International Plant Protection Convention (e.g. ISPM number) [X] None Does this proposed regulation conform to the relevant international standard? [ ] Yes [ ] No If no, describe, whenever possible, how and why it deviates from the international standard: |
9. | Other relevant documents and language(s) in which these are available: Canada Gazette, Part I, 14 January 2012, Pages 28-29 (available in English and French) |
10. | Proposed date of adoption (dd/mm/yy): Immediate for this IMA. For the final regulation, normally within 12-18 months of publication of the Notice of Interim Marketing Authorization in the Canada Gazette, Part I, 14 January 2012.
Proposed date of publication (dd/mm/yy): |
11. | Proposed date of entry into force: [ ] Six months from date of publication, and/or (dd/mm/yy): Immediate for this IMA. For the final regulation, normally within 12-18 months of publication of the Notice of Interim Marketing Authorization in the Canada Gazette, Part I, 14 January 2012.
[ ] Trade facilitating measure |
12. | Final date for comments: [ ] Sixty days from the date of circulation of the notification and/or(dd/mm/yy): 29 March 2012
Agency or authority designated to handle comments: [ ] National Notification Authority, [X] National Enquiry Point. Address, fax number and e‑mail address (if available) of other body: |
13. | Texts available from: [ ] National Notification Authority, [X] National Enquiry Point. Address, fax number and e‑mail address (if available) of other body:
The electronic version of the regulatory text can be downloaded at: http://www.gazette.gc.ca/rp-pr/p1/2012/2012-01-14/pdf/g1-14602.pdf#page=8 (Canada Gazette) or http://www.gazette.gc.ca/rp-pr/p1/2012/2012-01-14/html/notice-avis-eng.html#d106 (English) http://www.gazette.gc.ca/rp-pr/p1/2012/2012-01-14/html/notice-avis-fra.html#d106 (French) |